BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23346881)

  • 1. Infection-related hospital admissions after transrectal biopsy of the prostate.
    Sanders A; Buchan N
    ANZ J Surg; 2013 Apr; 83(4):246-8. PubMed ID: 23346881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases.
    Pinkhasov GI; Lin YK; Palmerola R; Smith P; Mahon F; Kaag MG; Dagen JE; Harpster LE; Reese CT; Raman JD
    BJU Int; 2012 Aug; 110(3):369-74. PubMed ID: 22313996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.
    Adibi M; Pearle MS; Lotan Y
    BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis.
    Adibi M; Hornberger B; Bhat D; Raj G; Roehrborn CG; Lotan Y
    J Urol; 2013 Feb; 189(2):535-40. PubMed ID: 22982426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy.
    Marino K; Parlee A; Orlando R; Lerner L; Strymish J; Gupta K
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7273-5. PubMed ID: 26369958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study.
    Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A
    Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy.
    Cam K; Kayikci A; Akman Y; Erol A
    Int J Urol; 2008 Oct; 15(11):997-1001. PubMed ID: 18721198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of urinary tract infection, or urosepsis following transrectal ultrasound-guided prostate biopsy in a subset of the Saudi population and patterns of susceptibility to flouroquinolones.
    AlKhateeb SS; AlShammari NA; AlZughaibi MA; Ghazwani YG; Alrabeeah KA; Albqami NM
    Saudi Med J; 2016 Aug; 37(8):860-3. PubMed ID: 27464862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.
    Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM
    BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
    Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
    Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative.
    Womble PR; Dixon MW; Linsell SM; Ye Z; Montie JE; Lane BR; Miller DC; Burks FN;
    J Urol; 2014 Jun; 191(6):1787-92. PubMed ID: 24345442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?
    Carignan A; Roussy JF; Lapointe V; Valiquette L; Sabbagh R; Pépin J
    Eur Urol; 2012 Sep; 62(3):453-9. PubMed ID: 22575912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.
    Nam RK; Saskin R; Lee Y; Liu Y; Law C; Klotz LH; Loblaw DA; Trachtenberg J; Stanimirovic A; Simor AE; Seth A; Urbach DR; Narod SA
    J Urol; 2010 Mar; 183(3):963-8. PubMed ID: 20089283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy.
    Lee C; You D; Jeong IG; Hong JH; Choo MS; Ahn H; Ahn TY; Kim CS
    Korean J Urol; 2015 Jun; 56(6):466-72. PubMed ID: 26078845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based linkage of health records to detect urological complications and hospitalisation following transrectal ultrasound-guided biopsies in men suspected of prostate cancer.
    Ganeswaran D; Sweeney C; Yousif F; Lang S; Goodman C; Nabi G
    World J Urol; 2014 Apr; 32(2):309-15. PubMed ID: 22736233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen.
    Williamson DA; Roberts SA; Paterson DL; Sidjabat H; Silvey A; Masters J; Rice M; Freeman JT
    Clin Infect Dis; 2012 May; 54(10):1406-12. PubMed ID: 22419681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
    Song W; Choo SH; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG
    Urology; 2014 Nov; 84(5):1001-7. PubMed ID: 25443894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of sepsis following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon.
    Shahait M; Degheili J; El-Merhi F; Tamim H; Nasr R
    Int Braz J Urol; 2016; 42(1):60-8. PubMed ID: 27136468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies.
    Luong B; Danforth T; Visnjevac O; Suraf M; Duff M; Chevli KK
    Urology; 2015 Mar; 85(3):511-6. PubMed ID: 25596154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The state of TRUS biopsy sepsis: readmissions to Victorian hospitals with TRUS biopsy-related infection over 5 years.
    Roth H; Millar JL; Cheng AC; Byrne A; Evans S; Grummet J
    BJU Int; 2015 Oct; 116 Suppl 3():49-53. PubMed ID: 26176815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.